Despite initial enthusiasm that hexanucleotide repeats account for most of the ALS-FTD cohort (112, 113), it has quickly become apparent that C9orf72 hexanucleotide repeats only explain a minority of ALS-FTD cases (114). Here, C9orf72 is linked to frontotemporal dementia.